Shepherd Financial Partners LLC Sells 1,234 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Shepherd Financial Partners LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,216 shares of the exchange traded fund’s stock after selling 1,234 shares during the period. Shepherd Financial Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $830,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Sanctuary Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $1,247,000. GAMMA Investing LLC raised its holdings in SPDR S&P Biotech ETF by 7,173.3% in the 3rd quarter. GAMMA Investing LLC now owns 1,091 shares of the exchange traded fund’s stock worth $108,000 after purchasing an additional 1,076 shares in the last quarter. CWM LLC raised its holdings in SPDR S&P Biotech ETF by 22.0% in the 3rd quarter. CWM LLC now owns 10,239 shares of the exchange traded fund’s stock worth $1,012,000 after purchasing an additional 1,849 shares in the last quarter. Carnegie Investment Counsel lifted its position in shares of SPDR S&P Biotech ETF by 3.2% in the 3rd quarter. Carnegie Investment Counsel now owns 95,423 shares of the exchange traded fund’s stock worth $9,428,000 after purchasing an additional 2,975 shares during the period. Finally, Shaker Investments LLC OH boosted its stake in shares of SPDR S&P Biotech ETF by 63.5% during the 3rd quarter. Shaker Investments LLC OH now owns 9,575 shares of the exchange traded fund’s stock valued at $946,000 after purchasing an additional 3,720 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $91.24 on Friday. The company has a 50-day simple moving average of $92.58 and a two-hundred day simple moving average of $96.50. The firm has a market capitalization of $6.95 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.